Enanta Pharmaceuticals | 流动资产





流动资产 更改 日
AbbVie USD 28.54B 722M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
AstraZeneca USD 29.94B 1B 2025-09
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Enanta Pharmaceuticals USD 204.34M 18.37M 2025-09
Gilead Sciences USD 18.84B 4.12B 2025-09
GlaxoSmithKline GBP 17.51B 332M 2025-12
Halozyme Therapeutics USD 1.33B 206.08M 2025-09
Heron Therapeutics USD 229.4M 18.48M 2025-09
Immunic USD 39.27M 20.57M 2025-09
Incyte USD 5.02B 746.01M 2025-12
Insmed USD 1.93B 149.77M 2025-09
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
J&J USD 54.61B 113M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Ligand Pharmaceuticals USD 753.92M 400.98M 2025-09
Merck USD 47.56B 10.49B 2025-09
Neurocrine Biosciences USD 2.16B 409.5M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Novavax USD 974.59M 55.08M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Vertex Pharmaceuticals USD 10.57B 141.7M 2025-09


Enanta Pharmaceuticals 流动资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.